Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Learn More About Tukysa Once it is Out in the Korean Market
Sponsor: Pfizer
Summary
The objectives of the re-examination system in Korea is to re-confirm the clinical usefulness of the product through collecting, reviewing, identifying and verifying the safety and efficacy information about the product in general practice in Korea. This surveillance is conducted for preparing application material for re-examination under the Pharmaceutical Affairs Laws, the Regulations on Safety of Pharmaceuticals, etc. and the Re-examination Regulation for New Drugs and Others.
Official title: Post-Approval Safety Monitoring Program to Assess the Safety and Efficacy Profile of TUKYSA in Usual Practice
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
600
Start Date
2027-01-01
Completion Date
2029-05-01
Last Updated
2025-11-17
Healthy Volunteers
No